Archives
-
Measuring Cancer Drug Responses Beyond Viability
2026-08-15
Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these measurements capture overlapping but non-equivalent aspects of cancer drug response. Its central implication is methodological: growth inhibition and cell killing should be measured and interpreted together, particularly when response magnitude and timing differ across compounds.
-
Dietary Arachidonic Acid and Humoral Immunity
2026-08-14
The reference study identifies dietary Arachidonic Acid as a potential adjuvant that accelerates vaccine-induced neutralizing antibody responses in mice and human volunteers. Its mechanistic contribution is the connection of lymph-node arachidonate metabolism to PGI2–cAMP–PKA signaling, CD86 expression, AID activation, and germinal-center B-cell maturation.
-
MK-5108 (VX-689) Aurora A Workflows
2026-08-14
Build sharper Aurora A experiments with MK-5108 (VX-689), from concentration-controlled cell-cycle assays to translational xenograft study design. Its strong biochemical selectivity helps distinguish Aurora A biology from broader Aurora kinase effects, while retinoblastoma findings provide a rationale for biomarker-guided testing.
-
Nifedipine (BAY-a-1040) and PXR
2026-08-13
A translational framework for using Nifedipine (BAY-a-1040) to interrogate calcium influx, iron metabolism, hepatic adaptation, and experimentally distinct cross-domain phenotypes.
-
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-08-13
The Tricine-SDS-PAGE Gel Preparation Kit is designed for high-resolution separation of low-molecular-weight proteins and peptides that can be difficult to resolve with conventional Tris-SDS-PAGE. It is intended for scientific research workflows, including denaturing and non-denaturing electrophoresis, and must not be used for diagnostic, clinical, or medical purposes.
-
H5N1 mRNA Vaccine Protection in Lactating Cows
2026-08-12
A hemagglutinin-based mRNA–lipid nanoparticle vaccine protected lactating dairy cows from high-dose H5N1 challenge and produced no reported health or milk-production concerns. The study is notable for showing durable protection even when serum antibody levels had declined, while also defining important boundaries for translating the findings into modified-mRNA manufacturing workflows.
-
Nile Red as a Quantitative Lipid Stress Sensor
2026-08-12
Nile Red can do more than reveal lipid droplets: its dual fluorescence supports compartment-aware lipid distribution imaging and more rigorous lipid storage dynamics analysis. This article connects Nile Red assay design with the multiparametric reasoning used in a mechanistic biofilm study, while defining the limits of cross-domain interpretation.
-
Amitriptyline HCl: Practical Workflow Guide
2026-08-11
Amitriptyline HCl (SKU B2231) provides a defined, high-purity small-molecule tool for receptor-modulation and neuropharmacology research where controlled solvent preparation and fresh use are practical. It is not a substitute for disease-specific validation, and long-term storage of prepared solutions should be avoided.
-
Gemcitabine and GPX3: Assays for Chemosensitivity
2026-08-11
Gemcitabine is a DNA synthesis inhibitor used to study checkpoint signaling, apoptosis, and cancer-cell chemosensitivity. This article develops a biomarker-aware assay framework based on the GPX3–JNK/c-Jun study, helping researchers distinguish replication stress from durable therapeutic response.
-
GSK-923295: Practical CENP-E Assay Guide
2026-08-10
This scenario-driven guide explains how GSK-923295 (SKU A3450) can support interpretable cell proliferation, viability, and mitotic phenotyping workflows. It covers mechanism, solvent handling, dose-response design, CTCF-related comparisons, and practical vendor-selection criteria using product and literature-based data.
-
VERTIS CV: Ertugliflozin Cardiovascular Outcomes
2026-08-09
The VERTIS CV trial established that Ertugliflozin was noninferior to placebo for major adverse cardiovascular events in adults with type 2 diabetes and established atherosclerotic cardiovascular disease. Its rigorous event-driven design supports cardiovascular safety interpretation while showing that possible benefits for heart-failure and renal outcomes require cautious, endpoint-specific assessment.
-
7-Ethyl-10-hydroxycamptothecin: Assay Logic
2026-08-08
7-Ethyl-10-hydroxycamptothecin (SN-38) is more than a TOP1 inhibitor: it enables a layered strategy for connecting DNA damage, FUBP1–FUSE disruption, cell-cycle arrest, and apoptosis. This article translates the evidence into practical assay decisions for advanced colon cancer research.
-
Selective Hypothermic Albumin Perfusion in Stroke
2026-08-07
This study evaluates intra-arterial selective cooling human serum albumin infusion as a targeted strategy for reducing cerebral ischemia-reperfusion injury after experimental stroke. Compared with cooling saline, saline alone, or albumin alone, the combined intervention improved neurological recovery, reduced neuroinflammation, and protected the blood-brain barrier through modulation of the ROCK1/MLC–F-actin axis.
-
Mitoxantrone HCl: DNA Topoisomerase II Inhibitor in Research
2026-08-07
Mitoxantrone HCl stands out as a DNA topoisomerase II inhibitor that not only induces DNA damage and apoptosis, but also uniquely disrupts estrogen receptor signaling in therapy-resistant cancer models. Its versatility across apoptosis induction in stem cells, leukemia research, and advanced nuclear receptor studies makes it indispensable for innovative biomedical workflows.
-
Atrial Natriuretic Peptide (ANP), rat: Mechanism & Research
2026-08-06
Atrial Natriuretic Peptide (ANP) is a rigorously characterized peptide hormone essential in cardiovascular research. As a potent vasodilator and regulator of natriuresis, the ANP peptide hormone is widely used to investigate blood pressure homeostasis and metabolic signaling. APExBIO's rat ANP (C49H84N20O15S) provides >95% purity and validated benchmarks for reproducible, mechanistic studies.